Clinical Trial Update: Effects of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 clinical trial evaluating teriparatide for osteoporosis in postmenopausal women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• Forteo (teriparatide)
• Teriparatide (Teriparatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Osteoporosis, Postmenopausal | Phase 3 | Status: COMPLETED